MOLECULAR BASIS OF BLOOD GROUP ANTIGENS
MOLECULAR BASIS OF BLOOD GROUP ANTIGENS
批准号:
2029423
负责人:
COLVIN M REDMAN
金额:
$99.88万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-02-01 至 2000-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The objectives are 1) To introduce, to the blood banking community, more
exact and convenient methods for determining red cell antigens and
identifying antibodies by studying the molecular basis of blood groups
with emphasis on the identification of allelic variations. 2) To
determine structure/function relationships of some red cell blood groups.
3) To link specific blood group genotypes with disease processes and to
understand the basis for the disease. To accomplish these goals we have
a collaborative program composed of five projects. Four projects
investigate the molecular and cell biology of Rh (Project 1), Kell
(Project 2), Duffy (Project 3) and Xg (Project 4) blood groups and project
5 is a clinical component which will apply molecular biology procedures to
improving the detection of antibodies and antigens as practiced in a blood
bank reference laboratory. Project 1 aims to construct a physical map of
the entire Rh locus and determine the order, transcriptional orientation
and expression of the major Rh genes. This will lead to understanding the
molecular basis of many Rh-related antigens, which is important in blood
transfusion, autoimmune hemolytic disease and in hemolytic disease of the
newborn (HDN). Kell blood group system incompatibilities also present
difficulties in blood transfusion and HDN. Kell antigens reside on a
surface exposed glycoprotein with homology to zinc neutral endopeptidases.
An aim of Project 2 is to determine the possible role of red cell surface
peptidases. Duffy glycoprotein (gpFy), on red cells, acts as a chemokine
receptor and also as a binding site for the human malarial parasite
Plasmodium vivax. Duffy protein is also found in other tissues such as
kidney, lung, thymus and brain. Project 3 aims to determine the function
of gpFy in these tissues and, by studying the structure of gpFy, design
ways to prevent P. vivax invasion. Project 4 will determine whether Xg
blood group is involved in cell interactions. In addition to
hematopoietic tissues Xg is found in fibroblasts and is homologous to a
product of the MIC 2 gene. Project 5 will use synthetic and recombinant
peptides, and allelic-specific transfectants to analyze antibodies in
patients. Information on the molecular basis of Rh, Kell, Duffy and Xg
blood groups (Projects 1-4) will also be used to introduce new procedures
for the identification of blood group antigens. This will impact on pre-
natal determination of whether a fetus is at risk for HDN and should be
useful in screening for antigen-negative blood for certain immunized
patients, such as those with Sickle Cell disease. The five projects are
supported by three Core units; administrative, cell culture and cell
sorting. The cell culture unit will provide training to investigators,
isolate CD34+ cells from hematopoietic tissues, culture progenitor cells
and prepare tested reagents for primary hematopoietic cultures. The cell
sorting unit will sort and analyze, by flow cytometry, hematopoietic stem
cells, committed progenitor cells and other hematopoietic cells with
different degrees of differentiation. Overall these 5 projects provide an
integrated approach to studying the molecular and cell biology of blood
groups and applying the knowledge gained to modernize blood banking
procedures and understand the functions of some blood groups and their
possible relations to diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
KELL BLOOD GROUP SYSTEM
-
批准号:6840410
-
项目类别:
-
资助金额:$37.03万
-
财政年份:2004
-
负责人:COLVIN M REDMAN
-
依托单位:
KELL BLOOD GROUP SYSTEM AND THE MCLEOD PHENOTYPE
-
批准号:6302331
-
项目类别:
-
资助金额:$23.65万
-
财政年份:2000
-
负责人:COLVIN M REDMAN
-
依托单位:
KELL BLOOD GROUP SYSTEM AND THE MCLEOD PHENOTYPE
-
批准号:6110459
-
项目类别:
-
资助金额:$23.65万
-
财政年份:1999
-
负责人:COLVIN M REDMAN
-
依托单位:
KELL BLOOD GROUP SYSTEM AND THE MCLEOD PHENOTYPE
-
批准号:6273043
-
项目类别:
-
资助金额:$18.78万
-
财政年份:1998
-
负责人:COLVIN M REDMAN
-
依托单位:
KELL BLOOD GROUP SYSTEM AND THE MCLEOD PHENOTYPE
-
批准号:6242453
-
项目类别:
-
资助金额:$16.65万
-
财政年份:1997
-
负责人:COLVIN M REDMAN
-
依托单位:
MOLECULAR BASIS OF BLOOD GROUP ANTIGENS
-
批准号:2232823
-
项目类别:
-
资助金额:$85.47万
-
财政年份:1996
-
负责人:COLVIN M REDMAN
-
依托单位:
MOLECULAR BASIS OF BLOOD GROUP ANTIGENS
-
批准号:2857855
-
项目类别:
-
资助金额:$141.88万
-
财政年份:1996
-
负责人:COLVIN M REDMAN
-
依托单位:
MOLECULAR BASIS OF BLOOD GROUP ANTIGENS
-
批准号:2638050
-
项目类别:
-
资助金额:$112.7万
-
财政年份:1996
-
负责人:COLVIN M REDMAN
-
依托单位:
MOLECULAR BASIS OF BLOOD GROUP ANTIGENS
-
批准号:6139179
-
项目类别:
-
资助金额:$147.07万
-
财政年份:1996
-
负责人:COLVIN M REDMAN
-
依托单位:
SMALL INSTRUMENTATION GRANT
-
批准号:3525823
-
项目类别:
-
资助金额:$2.43万
-
财政年份:1993
-
负责人:COLVIN M REDMAN
-
依托单位:
KELL BLOOD GROUP PROTEINS IN NORMAL AND MCLEOD RED CELLS
-
批准号:3346091
-
项目类别:
-
资助金额:$3.06万
-
财政年份:1992
-
负责人:COLVIN M REDMAN
-
依托单位:
FIBRINOGEN--MECHANISM OF ASSEMBLY
-
批准号:2714001
-
项目类别:
-
资助金额:$32.82万
-
财政年份:1987
-
负责人:COLVIN M REDMAN
-
依托单位:
HUMAN FIBRINOGEN--MECHANISM OF ASSEMBLY
-
批准号:3353126
-
项目类别:
-
资助金额:$21.67万
-
财政年份:1987
-
负责人:COLVIN M REDMAN
-
依托单位:
HUMAN FIBRINOGEN: MECHANISMS OF ASSEMBLY
-
批准号:3353128
-
项目类别:
-
资助金额:$13.06万
-
财政年份:1987
-
负责人:COLVIN M REDMAN
-
依托单位:
HUMAN FIBRINOGEN: MECHANISMS OF ASSEMBLY
-
批准号:3353124
-
项目类别:
-
资助金额:$12.79万
-
财政年份:1987
-
负责人:COLVIN M REDMAN
-
依托单位:
HUMAN FIBRINOGEN: MECHANISM OF ASSEMBLY
-
批准号:3353130
-
项目类别:
-
资助金额:$26.08万
-
财政年份:1987
-
负责人:COLVIN M REDMAN
-
依托单位:
HUMAN FIBRINOGEN: MECHANISMS OF ASSEMBLY
-
批准号:3353127
-
项目类别:
-
资助金额:$13.54万
-
财政年份:1987
-
负责人:COLVIN M REDMAN
-
依托单位:
HUMAN FIBRINOGEN: MECHANISM OF ASSEMBLY
-
批准号:3353131
-
项目类别:
-
资助金额:$26.69万
-
财政年份:1987
-
负责人:COLVIN M REDMAN
-
依托单位:
FIBRINOGEN--MECHANISM OF ASSEMBLY
-
批准号:2218466
-
项目类别:
-
资助金额:$30.74万
-
财政年份:1987
-
负责人:COLVIN M REDMAN
-
依托单位:
FIBRINOGEN--MECHANISM OF ASSEMBLY
-
批准号:2218465
-
项目类别:
-
资助金额:$29.75万
-
财政年份:1987
-
负责人:COLVIN M REDMAN
-
依托单位: